VSIR and neoplasm: Studies using VISTA-deficient mice or blocking monoclonal antibodies (mAbs) have demonstrated that VISTA is involved in tumor immune escape and autoimmune diseases (Ceeraz et al. 2017; Han et al. 2019; Wang et al. 2014).